RNA-Seq Data From Early Stage Triple Negative Breast Cancer Tumors Treated With TVEC and Chemotherapy (MCC18621)
Demographics (3)
- AGE - Subject age at enrollment (phv00528092.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00528099.v1.p1)
- SEX - Biological sex (phv00528087.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for breast cancer; all subjects are breast cancer patients. (phv00528091.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00528097.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00528096.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00528086.v1.p1)
- DIAGNOSIS - Diagnosis of the tumor (phv00528101.v1.p1)
- IS_TUMOR - Indication if sample is tumor (phv00528098.v1.p1)
- OUTCOME_PCR - Patient outcome of pathological complete response (phv00528093.v1.p1)
- OUTCOME_RCB - Patient outcome of residual cancer burden (phv00528094.v1.p1)
- SAMPLE_COLLECTION - Sample collection time relevant to treatment (phv00528100.v1.p1)
- SAMPLE_ID - Sample ID (phv00528095.v1.p1)
- SAMPLE_ID - Sample ID (phv00528089.v1.p1)
- STAGE_N - N categories of the TNM Staging System (phv00528103.v1.p1)
- STAGE_T - T categories of the TNM Staging System (phv00528102.v1.p1)
- SUBJECT_ID - Subject ID (phv00528090.v1.p1)
- SUBJECT_ID - Subject ID (phv00528085.v1.p1)
- SUBJECT_ID - Subject ID (phv00528088.v1.p1)